Article

Download article 		Title: nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth
Author: Fort, R.; Mendez, L.; Garat, B.; Kimura, E. T.; Sotelo-silveira, J. R.; Duhagon, M. A.; Matho, C.; Geraldo, M. V.; Ottati, M. C.; Yamashita, A. S.; Saito, K.; Leite, K. R.; Mendez, M.; Maedo, N.
Year: 2018
Is part of: BMC CANCER, v. 18, p. 1 - 13
DOI: https://doi.org/10.1186/s12885-018-4049-7

Citation: Fort, R.; Mendez, L.; Garat, B.; Kimura, E. T.; Sotelo-silveira, J. R.; Duhagon, M. A.; Matho, C.; Geraldo, M. V.; Ottati, M. C.; Yamashita, A. S.; Saito, K.; Leite, K. R.; Mendez, M.; Maedo, N.; nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. BMC CANCER, v.18, p. 1-13, 2018

Financed by: